AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,775,593 | -53.3% | 228,519 | -41.8% | 0.00% | – |
| Q2 2023 | $3,798,606 | +63.5% | 392,418 | +85.2% | 0.00% | – |
| Q1 2023 | $2,323,000 | +380719.7% | 211,942 | +50.3% | 0.00% | – |
| Q4 2022 | $610 | -99.9% | 141,010 | +86.6% | 0.00% | – |
| Q3 2022 | $568,000 | -21.8% | 75,564 | +4.6% | 0.00% | – |
| Q2 2022 | $726,000 | +672.3% | 72,274 | +847.9% | 0.00% | – |
| Q1 2022 | $94,000 | +17.5% | 7,625 | +117.2% | 0.00% | – |
| Q4 2021 | $80,000 | -39.8% | 3,511 | -41.6% | 0.00% | – |
| Q3 2021 | $133,000 | +68.4% | 6,010 | -1.4% | 0.00% | – |
| Q2 2021 | $79,000 | +7800.0% | 6,095 | +10058.3% | 0.00% | – |
| Q4 2020 | $1,000 | -98.8% | 60 | -98.5% | 0.00% | – |
| Q4 2019 | $81,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |